Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Dentistry, root canal, clinical trial, Nanodiamonds, Infection, gutta percha

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2017 3:00 PM EDT

Medicine

Channels:

zika, Zika birth defects, Zika infection, microcephaly , Brain Damage, brain damage infants, Brain Research, brain organoids, Stem Cells, Stem Cell Research, Neurodevelopment, Neurodevelopment Disabilities, Neurodevelopment Disorder, neurodevelopmental abnormalities, Neurologic Conditions, neurologic disease, disease modeling, Drug Screening, Drug Screening Technology, Epilepsy, Autism, schizophrenia and vision , schizophren, Broad Stem Cell Research Center at UCLA

Better ‘Mini Brains’ Could Help Scientists Identify Treatments for Zika-Related Brain Damage

organoidandZika_800x533.jpg

UCLA researchers have developed an improved technique for creating simplified human brain tissue from stem cells. Because these so-called “mini brain organoids” mimic human brains in how they grow and develop, they’re vital to studying complex neurological diseases.

Medicine

Channels:

Glioblastoma, Treatment, Brain Cancer

Combination Treatment Targeting Glucose in Advanced Brain Cancer Shows Promising Results in Preclinical Study

PETimagespreandpost-textcropNathanson.jpg

UCLA scientists have discovered a potential combination treatment for glioblastoma, the deadliest form of brain cancer in adults. The three-year study led by Dr. David Nathanson, a member of UCLA's Jonsson Comprehensive Cancer Center, found that the drug combination tested in mice disrupts and exploits glucose intake, essentially cutting off the tumor's nutrients and energy supply. This treatment then stimulates cell death pathways-which control the cancer cells' fate- and prevents the glioblastoma from getting bigger.

Medicine

Channels:

Breast Cancer, Breast Cancer Awareness Month, Cancer, Mammogram, HER, Her 2, Her-2 protein, HER-2 receptor, Hematology, Oncology, HemOnc, Herceptin, Ucla Medical Center, UCLA Jonsson Cancer Center

Breast Cancer Treatment Has Evolved. Here’s Where We Are.

SaraHurvitz.jpg

Targeted therapies are now available for approximately 85 percent of women diagnosed with breast cancer.

Medicine

Science

Channels:

HIV, AIDS, HIV Reservoirs, dormant HIV, kick and kill

Researchers Create Molecule That Could ‘Kick and Kill’ HIV

HIV_mid.jpg

Scientists have developed an agent to “wake up” HIV lying dormant in cells, which causes it to begin replicating so that either the immune system or the virus itself would kill the cell harboring HIV. They call the technique “kick and kill.”

Medicine

Channels:

Healthcare Costs, Affordable Care Act (ACA), Low-Value Care, low-value services, high-volume healthcare services, fee-for-service Medicare, Medicare, Medicare advantage, Medicaid, private health insurance , out-of-pocket healthcare costs

Low-Cost, High-Volume Services Make Up Big Portion of Spending on Unneeded Health Care

BloodLabTest.jpg

Low-cost, high-volume health services account for a high percentage of unnecessary health spending, adding strain to the health care system.

Medicine

Life

Education

Channels:

College, Depression, Stress, failure to thrive, Cognitive Behavior, Anxiety, Empty Nest Syndrome, UCLA, David Geffen School of Medicine at UCLA, Ucla Medical Center, Psychology

UCLA Expert on Depression and Its Impact on Success at College

Maidenberg.Emanuel.jpg

People with vulnerability towards depression and anxiety frequently experience the onset of such disorders around age 18.

Medicine

Science

Channels:

Black Tea May Help with Weight Loss, Too

UCLA researchers have demonstrated for the first time that black tea may promote weight loss and other health benefits by changing bacteria in the gut.

Medicine

Channels:

After Clinical Testing at UCLA, Immunotherapy Drug Approved by FDA to Treat Stomach Cancer

Wainberg2011.jpg

Pembrolizumab, a drug that has effectively extended the lives of countless people with many types of cancer, has now been approved by the U.S. Food & Drug Administration to treat people with metastatic gastric adenocarcinoma, the most common form of stomach cancer. The research that led to the approval was conducted at UCLA and 67 other sites in the U.S., Europe, South America and Asia.

Science

Channels:

HIV and AIDS, Substance Abuse, NIDA, National Institute On Drug Abuse, men who have sex with men, MSM, Minorities, Minorities and AIDS, Minorities and HIV, HIV-positive, HIV-negative, Research, Statistics, data

UCLA Receives $5 Million Grant for Sharing Research on AIDS and Substance Abuse

The National Institute on Drug Abuse has awarded $5 million to researchers at UCLA to develop a resource and data center for millions of pieces of research, lab samples, statistics and other data aimed at boosting research into the effects of substance abuse on HIV/AIDS.







Chat now!